-
Symbol
-
BBOT on Nasdaq
-
Investment type
-
Equity / COMMON STOCK
-
Latest Disclosed Shares Owned
-
13,878,554 shares
-
Security Ownership %
-
18%
BridgeBio Pharma LLC ownership in BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT)
18 Aug 2025 - BridgeBio Pharma LLC has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,878,554 shares of BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT).
This represents 18% ownership of the company.
This is the first filing by BridgeBio Pharma LLC disclosing ownership of BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT).